Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Azaron
2. Histantin
3. Pyribenzamine
4. Tripelennamine
5. Tripelennamine Citrate (1:1)
6. Tripelennamine Hydrochloride
7. Tripelennamine Maleate
8. Tripelennamine Maleate (1:1)
9. Tripelennamine Monohydrochloride
10. Vetibenzamin
1. 6138-56-3
2. Tripelennamine (citrate)
3. Nsc-757360
4. 2-(benzyl(2-(dimethylamino)ethyl)amino)pyridine Citrate (1:1)
5. 30oc46a3j9
6. 1,2-ethanediamine, N,n-dimethyl-n'-(phenylmethyl)-n'-2-pyridinyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
7. Ncgc00095775-01
8. Dsstox_cid_25989
9. Dsstox_rid_81276
10. Dsstox_gsid_45989
11. N'-benzyl-n,n-dimethyl-n'-pyridin-2-ylethane-1,2-diamine;2-hydroxypropane-1,2,3-tricarboxylic Acid
12. Pyribenzamine Citrate
13. Cas-6138-56-3
14. Einecs 228-121-6
15. Tripelennamine Citrate [usp]
16. Unii-30oc46a3j9
17. Pbz (tn)
18. Schembl99166
19. Spectrum1500597
20. Chembl1200769
21. Dtxsid8045989
22. Hms501k16
23. Hms2092a14
24. Pharmakon1600-01500597
25. Tripelennamine Citrate [mi]
26. Tox21_111518
27. Ccg-39053
28. Hy-17428b
29. Nsc757360
30. Pyridine, 2-(benzyl(2-(dimethylamino)ethyl)amino)-, Citrate (1:1)
31. Tripelennamine Citrate [vandf]
32. Tox21_111518_1
33. Tripelennamine Citrate [mart.]
34. Nsc 757360
35. Tripelennamine Citrate [who-dd]
36. Ncgc00018125-05
37. Ncgc00095775-02
38. Tripelennamine Citrate [orange Book]
39. Cs-0030834
40. D06246
41. Sr-01000003013-4
42. Q27255968
43. 1,2-ethanediamine, N,n-dimethyl-n'-(phenylmethyl)-n'-2-pyridinyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (salt)
44. 1,2-ethanediamine, N1,n1-dimethyl-n2-(phenylmethyl)-n2-2-pyridinyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
45. N\'-benzyl-n,n-dimethyl-n\'-pyridin-2-ylethane-1,2-diamine,2-hydroxypropane-1,2,3-tricarboxylic Acid
| Molecular Weight | 447.5 g/mol |
|---|---|
| Molecular Formula | C22H29N3O7 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 11 |
| Exact Mass | 447.20055027 g/mol |
| Monoisotopic Mass | 447.20055027 g/mol |
| Topological Polar Surface Area | 152 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 464 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
ABOUT THIS PAGE
23
PharmaCompass offers a list of Tripelennamine Citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tripelennamine Citrate manufacturer or Tripelennamine Citrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tripelennamine Citrate manufacturer or Tripelennamine Citrate supplier.
PharmaCompass also assists you with knowing the Tripelennamine Citrate API Price utilized in the formulation of products. Tripelennamine Citrate API Price is not always fixed or binding as the Tripelennamine Citrate Price is obtained through a variety of data sources. The Tripelennamine Citrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tripelennamine Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tripelennamine Citrate, including repackagers and relabelers. The FDA regulates Tripelennamine Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tripelennamine Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tripelennamine Citrate supplier is an individual or a company that provides Tripelennamine Citrate active pharmaceutical ingredient (API) or Tripelennamine Citrate finished formulations upon request. The Tripelennamine Citrate suppliers may include Tripelennamine Citrate API manufacturers, exporters, distributors and traders.
Tripelennamine Citrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tripelennamine Citrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tripelennamine Citrate GMP manufacturer or Tripelennamine Citrate GMP API supplier for your needs.
A Tripelennamine Citrate CoA (Certificate of Analysis) is a formal document that attests to Tripelennamine Citrate's compliance with Tripelennamine Citrate specifications and serves as a tool for batch-level quality control.
Tripelennamine Citrate CoA mostly includes findings from lab analyses of a specific batch. For each Tripelennamine Citrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tripelennamine Citrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Tripelennamine Citrate EP), Tripelennamine Citrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tripelennamine Citrate USP).
